Y Intercept (Hong Kong) LTD Sutro Biopharma, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.83 Billion
- Q3 2025
Shares
2 transactions
Others Institutions Holding STRO
# of Institutions
92Shares Held
57.3MCall Options Held
75KPut Options Held
0-
Black Rock Inc. New York, NY6.91MShares$6.57 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.49MShares$6.16 Million0.17% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.09MShares$4.83 Million0.38% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$4.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$3.5 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $49.6M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...